NA
Noushad Abdulla Kunju
About Noushad Abdulla Kunju
Data last updated:
Noushad Abdulla Kunju is a Director at N4 Medicals Private Limited (since 2022) and Managing Director at N4 Medicals Gcc Private Limited (since 2025). The companies operate in Non-Profit Organizations and Pharma. The largest current company by reported revenue is N4 Medicals Private Limited at ₹51.4 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 N4 Medicals Private Limited U85300KL2022PTC074324 | Director | 08 Apr 2022 | 2022 | ₹51.4 Lakh (FY 2025) | Active |
| N4 Medicals Gcc Private Limited U46497KL2025PTC091717 | Managing Director | 28 Jan 2025 | 2025 | Active |
Board colleagues of Noushad Abdulla Kunju
| Name | DIN | Company | Designation |
|---|---|---|---|
| Noohu Abdul Khadar Nowshad | 06956843 | N4 Medicals Private Limited , N4 Medicals Gcc Private Limited | Director |
| Noushad Vadyaru Kandy | 09564547 | N4 Medicals Private Limited , N4 Medicals Gcc Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Noushad Abdulla Kunju
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Noushad Abdulla Kunju
Noushad Abdulla Kunju currently holds 2 directorships: N4 Medicals Private Limited (Director, since 08 Apr 2022, revenue ₹51.4 Lakh (FY 2025)); N4 Medicals Gcc Private Limited (Managing Director, since 28 Jan 2025).
Noushad Abdulla Kunju was first appointed on 08 Apr 2022 as Director at N4 Medicals Private Limited. The most recent appointment on record is 28 Jan 2025 at N4 Medicals Gcc Private Limited.
The current boards of Noushad Abdulla Kunju's companies include Noohu Abdul Khadar Nowshad (N4 Medicals Private Limited), Noushad Vadyaru Kandy (N4 Medicals Private Limited).